Table: begin end state 1 11 cytoplasmic 12 28 transmembrane 29 43 non-cytoplasmic 44 65 transmembrane 66 84 cytoplasmic 85 103 transmembrane 104 114 non-cytoplasmic 115 140 transmembrane 141 148 cytoplasmic 149 171 transmembrane 172 183 non-cytoplasmic 184 204 transmembrane 205 249 cytoplasmic 250 271 transmembrane 272 282 non-cytoplasmic 283 304 transmembrane 305 315 cytoplasmic 316 334 transmembrane 335 340 non-cytoplasmic 341 361 transmembrane 362 368 cytoplasmic 369 391 transmembrane 392 401 non-cytoplasmic 402 424 transmembrane 425 450 cytoplasmic
Input: >H281DRAFT_00981 FitnessBrowser__Burk376:H281DRAFT_00981 MELEARTMKRVTVRLVPFLIVCYFIAYLDRVNVGFAALQMNKALGLSASAFGFGAGIFFI AYFFFEVPSNLLLEKFGARRWIARIMFTWGLLAGAMAYIPHIAQYTGLSAAHVFYGLRIL LGVAEAGFFPGVIFLLTLWFPAAYRGRVVGYFMAAIPLSTVIGGPISGALLSMDGFAGLA GWQWVYLIEALPALILAFAVWFYLTDKPADATWLAADERDWLVARQKQEREHREAVHAFS VKEALLNRRVLAIALIYFGANATNYGLSFFLPQIVKAFGLTNLQTGFVTSLPYIVGVISM VYWGRHSDRKLERKRHVAIALTVAALGIAASAGLDNPVQKMIALSIAGFGIFGCLPVIWT LPAAFLSGAAAAGGIAAINSLGNLAGFFGPYAMGWIKDSTGGFGAGLLCLAGAGLVGAAA ALLLHHDPALEASAGTARRDASAGPPVAEY
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server